Mutya Harsch is a director of Satsuma Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
VYNE Therapeutics Inc.
3 Apr 24
4
VYNE Therapeutics Inc.
3 Jan 24
4
VYNE Therapeutics Inc.
15 Dec 23
4
VYNE Therapeutics Inc.
4 Oct 23
4
VYNE Therapeutics Inc.
5 Jul 23
4
Satsuma Pharmaceuticals, Inc.
8 Jun 23
4
VYNE Therapeutics Inc.
2 Jun 23
4
VYNE Therapeutics Inc.
4 Apr 23
4
VYNE Therapeutics Inc.
22 Mar 23
4
VYNE Therapeutics Inc.
4 Jan 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | VYNE VYNE Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 3.08 | 161 | 495.88 | 149,274 |
2 Jan 24 | VYNE VYNE Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 2.28 | 161 | 367.08 | 149,435 |
1 Jan 24 | VYNE VYNE Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 62,500 | 0.00 | 149,596 |
1 Jan 24 | VYNE VYNE Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.33 | 62,500 | 145.63 k | 62,500 |
13 Dec 23 | VYNE VYNE Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 62,500 | 0.00 | 87,096 |
13 Dec 23 | VYNE VYNE Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.7 | 62,500 | 168.75 k | 62,500 |
2 Oct 23 | VYNE VYNE Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 3.83 | 1,154 | 4.42 k | 24,596 |
8 Jun 23 | STSA Satsuma Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.46 | 30,000 | 103.80 k | 0 |
8 Jun 23 | STSA Satsuma Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.48 | 40,000 | 179.20 k | 0 |